Related Experiment Video

Updated: May 8, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Stent thrombosis after coronary stent implantation: a protective effect of high-dose statin therapy?

Raban V Jeger1, Hans Peter Brunner-La Rocca, Osmund Bertel

  • 1Cardiology, University Hospital Basel, Basel, Switzerland.

Cardiology
|August 17, 2013
PubMed

Insights

Statin use may protect against stent thrombosis (ST), a serious complication after coronary stent procedures. This finding suggests statins could be a key factor in preventing ST, warranting further investigation.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Biomedical Engineering

Background:

  • Stent thrombosis (ST) is a significant complication following coronary stent implantation.
  • Identifying independent predictors of ST is crucial for improving patient outcomes.

Purpose of the Study:

  • To assess independent predictors of stent thrombosis (ST) in an all-comer trial.
  • To investigate the role of statin therapy in relation to ST risk.

Main Methods:

  • Retrospective analysis of the Basel Stent Kosten Effektivitäts Trial (BASKET) dataset (n=826).
  • Case-control study comparing patients with ST to controls.
  • Multivariate logistic regression models to identify independent predictors of ST.

Main Results:

  • Independent predictors of ST included interventions in saphenous vein grafts, malapposed stents, stent overlap >3 mm, complex coronary anatomy, and low-dose/no statin use.
  • Risk factors for late ST specifically included interventions in saphenous vein grafts, underexpanded or malapposed stents, history of myocardial infarction, and low-dose/no statin use.
  • Patients with ST received lower doses of statins compared to controls.

Conclusions:

  • Statin therapy may exert a protective effect against stent thrombosis.
  • These findings are hypothesis-generating and suggest the need for adequately powered randomized trials to confirm the protective role of statins against ST.
Abstract

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...